换一批
换一批摘要由于老年患者本身的特点及疾病的生物学特征,老年急性髓系白血病(AML)患者的疗效及预后均较差.近年老年AML患者的治疗取得许多进展诸如标准化疗方案的改良、新化疗药物的应用、免疫治疗、表观遗传学治疗药物及靶向治疗药物的研发等,临床试验结果提示部分患者疗效改善.
更多相关知识
abstractsAcute myeloid leukemias (AML) in elderly patients showed less well response to therapy as well as relative poor prognosis, due to features of both host and disease biology in the elder. During the past decade, treatments for elderly AML have yielded some advances, including improvements in conventional chemotherapy, application of novel chemotherapeutic agents, immunotherapy approaches, and investigation of epigenetic drugs and targeted therapies, to which some subgroups in clinical trials have showed better response. These advances in current treatments of elderly AML will be reviewed.
More相关知识
- 浏览649
- 被引3
- 下载152
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
